CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implicationsKimihiko Kaneko, Masashi Aoki, Tatsuro Misu et al.|Journal of Neurology Neurosurgery & Psychiatry|2018Cited by 199
Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patientsDaniel Whittam, Brigitte Wildemann, Álvaro Cobo‐Calvo et al.|Multiple Sclerosis and Related Disorders|2020Cited by 179
Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodiesKimihiko Kaneko, Masashi Aoki, Douglas Kazutoshi Sato et al.|Journal of Neurology Neurosurgery & Psychiatry|2016Cited by 108
Atrophy Patterns in Patients With Multiple Sclerosis With Cognitive Impairment, Fatigue, and Mood DisordersCarolina de Medeiros Rimkus, Cláudia C. Leite, Mariana Penteado Nucci et al.|Neurology|2024Cited by 10